Canada markets closed

Evofem Biosciences, Inc. (EVFM)

OTC Markets OTCQB - OTC Markets OTCQB Delayed Price. Currency in USD
Add to watchlist
0.01300.0000 (0.00%)
At close: 03:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 806.78k
Enterprise Value 43.22M
Trailing P/E 0.01
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.81
Price/Book (mrq)N/A
Enterprise Value/Revenue 2.70
Enterprise Value/EBITDA -0.74

Trading Information

Stock Price History

Beta (5Y Monthly) -0.65
52-Week Change 3-98.70%
S&P500 52-Week Change 323.23%
52 Week High 31.4000
52 Week Low 30.0100
50-Day Moving Average 30.0148
200-Day Moving Average 30.0577

Share Statistics

Avg Vol (3 month) 3995.3k
Avg Vol (10 day) 3880.47k
Shares Outstanding 562.06M
Implied Shares Outstanding 662.06M
Float 862.06M
% Held by Insiders 10.00%
% Held by Institutions 10.17%
Shares Short (Jul 29, 2022) 469.46k
Short Ratio (Jul 29, 2022) 40.19
Short % of Float (Jul 29, 2022) 411.01%
Short % of Shares Outstanding (Jul 29, 2022) 410.98%
Shares Short (prior month Jun 30, 2022) 4142.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 18, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:125
Last Split Date 3May 18, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024


Profit Margin 315.54%
Operating Margin (ttm)-78.93%

Management Effectiveness

Return on Assets (ttm)-62.45%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)16.01M
Revenue Per Share (ttm)1.30
Quarterly Revenue Growth (yoy)-38.00%
Gross Profit (ttm)N/A
EBITDA -16.87M
Net Income Avi to Common (ttm)47.49M
Diluted EPS (ttm)1.7400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)42.41M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.09
Book Value Per Share (mrq)-1.45

Cash Flow Statement

Operating Cash Flow (ttm)-3.9M
Levered Free Cash Flow (ttm)2.74M